Action Potential Venture Capital
Cambridge, Massachusetts, United StatesFounded 2013
Action Potential Venture Capital (APVC) is a corporate venture capital arm of GSK that invests in bioelectronic medicines and technology companies. Founded in 2013, APVC supports entrepreneurs pioneering the journey to a bioelectronic future.
86% of their portfolio is in Healthcare. Average disclosed round size is $44.2M (across 20 rounds with reported amounts).
Portfolio
12
Fund Size
$50M
Top Stage
Series B
Last 12 Mo
0
Team
JM
Juan-Pablo Mas
Managing Director
SM
Suraj Mudichintala
Operating Partner
AD
Alexandra de Paz
Life Sciences Venture Capital
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
22 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Alpheus Medical | Series B | $52M | May 2025 |
 Cala Health | Series C | $50M | Mar 2025 |
 MicroTransponder | Series F | $65M | Mar 2025 |
| AAlpheus | Series B | $52M | Jan 2025 |
| Alpheus Medical | Series B | $52M | Jan 2025 |
| Cala Health | Growth | $50M | Dec 2024 |
| MicroTransponder | Series E | $73M | Sep 2022 |
| MicroTransponder | Series E | $53M | Jun 2022 |
 Neuspera Medical | Series C | $65M | Jul 2021 |
 SetPoint Medical | Series D | $64M | Jan 2021 |
| Cala Health | Series C | $50M | Jan 2021 |
 Exo | Series B | — | Aug 2020 |
 CVRx | Unknown | $50M | Jul 2020 |
 Presidio Medical | Series B | $30M | Jan 2020 |
| Neuspera Medical | Series B | $26M | Feb 2019 |
| Cala Health | Series C | $50M | Jan 2019 |
| Cala Health | Series A | $18M | Jan 2016 |
| SetPoint Medical | Series C | $25M | Sep 2015 |
| MicroTransponder | Unknown | $2.6M | Jan 2010 |
 Exo Imaging | Growth | — | — |
 Onc AI | Series A | $25M | — |
| AAxon Therapies | Series A | $32M | — |
Top Co-Investors
GV5 shared
Lightstone Ventures5 shared
Lux Capital5 shared
Triventures4 shared
U.S. Venture Partners4 shared
Osage University Partners4 shared
Ascension Ventures3 shared
PEAK6 Strategic Capital3 shared
HealthQuest Capital3 shared
BrightEdge3 shared
OrbiMed3 shared
Brain Tumor Investment Fund3 shared
Samsara BioCapital3 shared
Exceller Hunt Ventures3 shared
The Vertical Group3 shared
New Enterprise Associates3 shared
Gilde Healthcare3 shared
Green Park & Golf Ventures2 shared
Windham Capital Partners2 shared
True Ventures2 shared
Last updated: 20 October 2026